NanoString Technologies (NSTG) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NanoString Technologies Releases Financial Results for Second Quarter of 2015
August 4, 2015 4:05 PM EDTCancer Focus and Leadership in Immuno-Oncology Strengthened by Collaboration with Merck
Launch of nCounter SPRINT Broadens Reach in Cancer Research Market
SEATTLE, Aug. 4, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter ended June 30, 2015.
Second Quarter Financial Highlights:
Total revenue of $13.1 million, 20% year-over-year growth Total product and service revenue of $12.5 million, 22% year-over-year growth Instrument revenue of $4.4 million, 17%... More